Abacus Health Products (ABAHF) Stock Price, News & Analysis

Company Overview

Abacus Health Products is a Canadian-based company specializing in the development, manufacturing and marketing of natural health and wellness products. Headquartered in Vaughan, Ontario, the company operates under a fully integrated model that encompasses research and development, product formulation, manufacturing and distribution. Abacus Health Products has established itself as a provider of premium nutraceuticals, with a focus on combining traditional botanical ingredients and modern scientific methodologies.

The company’s product portfolio includes a broad array of vitamins, minerals, herbal extracts, probiotics and specialty formulations. Abacus is particularly known for its honeybee-derived products, such as royal jelly, propolis and bee pollen concentrates. These offerings are sold under various in-house brands and through contract-manufacturing partnerships, serving retailers, healthcare professionals and natural product distributors. In addition to consumer-facing lines, the company provides custom formulation and private-label services to third-party brands seeking cGMP-certified manufacturing capabilities.

Abacus Health Products’ manufacturing facility in Ontario is designed to meet stringent quality and safety standards, with dedicated laboratories for microbiology, stability testing and raw-material analysis. The company’s global reach extends throughout North America, Europe and select Asian markets, leveraging a network of distribution partners and regulatory experts to navigate diverse compliance requirements. Research collaborations with academic institutions and industry associations support ongoing product innovation and evidence-based validation of health claims.

The executive leadership team at Abacus brings together seasoned professionals in pharmaceutical sciences, quality assurance and consumer health marketing. Supported by a board of directors with extensive experience in regulatory affairs, supply-chain management and corporate governance, the company continues to pursue strategic growth through new product launches and market expansion. Abacus Health Products remains committed to sustainable sourcing practices, rigorous quality control and delivering scientifically backed wellness solutions to its global customer base.

Key Stats

• Today's Range: $4.60 to $5.50
• 50-Day Range: $4.84 to $4.84
• 52-Week Range: $1.12 to $8.40
• Volume: 9,300 shs
• Average Volume: 10,164 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABAHF Stock Analysis - Frequently Asked Questions

How have ABAHF shares performed this year?

Abacus Health Products' stock was trading at $4.84 at the beginning of 2025. Since then, ABAHF stock has increased by 0.0% and is now trading at $4.84.

How do I buy shares of Abacus Health Products?

Shares of ABAHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ABAHF
• CIK: N/A
• Web: abacushp.com
• Phone: N/A
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A